speb/financial-data huggingface dataset:
CI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 16658000000.00
CI cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 57000000.00
CI balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 52000000.00
CI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 29371000000.00
CI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 29371000000.00
CI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -550000000.00
CI income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 7924000000.00
CI balance_sheet (quarterly, 2026-03-31) — Minority Interest: 232000000.00
CI income_statement (quarterly, 2026-03-31) — Minority Interests: -207000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 20000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 57000000.00
CI balance_sheet (quarterly, 2026-03-31) — Net Debt: 23860000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income: 1654000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1654000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1861000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1654000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1654000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1861000000.00
CI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1861000000.00
CI income_statement (quarterly, 2026-03-31) — Net Interest Income: -357000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -254000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -563000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -550000000.00
CI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -357000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -218000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -136000000.00
CI balance_sheet (quarterly, 2026-03-31) — Net PPE: 3704000000.00
CI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -267000000.00
CI income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 7924000000.00
CI cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -13000000.00
CI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -30642000000.00
CI balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 4073000000.00
CI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6851000000.00
CI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6851000000.00
CI balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 2244000000.00
CI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2806000000.00
CI income_statement (quarterly, 2026-03-31) — Normalized Income: 1267780000.00
CI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1131000000.00
CI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -269000000.00
CI income_statement (quarterly, 2026-03-31) — Operating Income: 2156000000.00
CI income_statement (quarterly, 2026-03-31) — Operating Revenue: 63849000000.00
CI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 264498000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2742000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1529000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -3598000000.00
CI income_statement (quarterly, 2026-03-31) — Other Income Expense: 471000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 27318000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Investments: 5158000000.00
CI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 5000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 10703000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 12219000000.00
CI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 228000000.00
CI income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 8224000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Payable: 25763000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Receivables: 244000000.00
CI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 760000000.00
CI income_statement (quarterly, 2026-03-31) — Other Special Charges: -22000000.00
CI balance_sheet (quarterly, 2026-03-31) — Payables: 42097000000.00
CI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 51077000000.00
CI income_statement (quarterly, 2026-03-31) — Pretax Income: 2270000000.00
CI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -919000000.00
CI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -267000000.00
CI balance_sheet (quarterly, 2026-03-31) — Receivables: 26659000000.00
CI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 61764000000.00
CI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 650000000.00
CI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -550000000.00
CI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
CI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 49106000000.00
CI cash_flow (quarterly, 2026-03-31) — Sale Of Business: 20000000.00
CI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 665000000.00
CI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3722000000.00
CI balance_sheet (quarterly, 2026-03-31) — Share Issued: 405898000.00
CI income_statement (quarterly, 2026-03-31) — Special Income Charges: 11000000.00
CI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 42210000000.00
CI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -30642000000.00
CI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 84780000.00
CI income_statement (quarterly, 2026-03-31) — Tax Provision: 409000000.00
CI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
CI balance_sheet (quarterly, 2026-03-31) — Total Assets: 153266000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 71581000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Debt: 30900000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 42442000000.00
CI income_statement (quarterly, 2026-03-31) — Total Expenses: 66136000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 110824000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 110234000000.00
CI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 58218000000.00
CI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 2358000000.00
CI income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 1428000000.00
CI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 471000000.00
CI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 471000000.00
CI balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 9777000000.00
CI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 141400000.00
CI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 35216000000.00
CI balance_sheet (quarterly, 2026-03-31) — Working Capital: -9574000000.00
CIA cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 12624000.00
CIA cash_flow (annual, 2021-12-31) — Common Stock Issuance: 2255000.00
CIA balance_sheet (annual, 2021-12-31) — Dividends Payable: 37760000.00
CIA balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 941000.00
CIA income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 12624000.00
CIA cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 1200000.00
CIA balance_sheet (annual, 2021-12-31) — Income Tax Payable: 0.00
CIA cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 2255000.00
CIA income_statement (annual, 2021-12-31) — Other Operating Expenses: -186000.00
CIA income_statement (annual, 2021-12-31) — Other Special Charges: -13000.00
CIA cash_flow (annual, 2021-12-31) — Sale Of PPE: 14000.00
CIA income_statement (annual, 2021-12-31) — Special Income Charges: -12611000.00
CIA balance_sheet (annual, 2021-12-31) — Total Tax Payable: 0.00
CIA income_statement (annual, 2021-12-31) — Total Unusual Items: -12611000.00
CIA income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -12611000.00
CIA balance_sheet (annual, 2021-12-31) — Unrealized Gain Loss: 117492000.00
CIA income_statement (annual, 2022-12-31) — +Total Revenue: 232524000.00
CIA balance_sheet (annual, 2022-12-31) — Accounts Payable: 9884000.00
CIA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 16389000.00
CIA cash_flow (annual, 2022-12-31) — Amortization Of Securities: -5648000.00
CIA cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CIA income_statement (annual, 2022-12-31) — Basic Average Shares: 50139000.00
CIA income_statement (annual, 2022-12-31) — Basic EPS: 0.52
CIA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 27294000.00
CIA cash_flow (annual, 2022-12-31) — Capital Expenditure: -100000.00
CIA balance_sheet (annual, 2022-12-31) — Capital Stock: 271331000.00
CIA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 22973000.00
CIA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1203833000.00
CIA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -499000.00
CIA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -60742000.00
CIA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 56920000.00
CIA cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 161000.00
CIA cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -674000.00
CIA cash_flow (annual, 2022-12-31) — Change In Payable: 12813000.00
CIA cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 12813000.00
CIA cash_flow (annual, 2022-12-31) — Change In Receivables: -102000.00
CIA cash_flow (annual, 2022-12-31) — Change In Tax Payable: 161000.00
CIA cash_flow (annual, 2022-12-31) — Change In Working Capital: 23350000.00
CIA cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -102000.00
CIA cash_flow (annual, 2022-12-31) — Changes In Cash: -4321000.00
CIA balance_sheet (annual, 2022-12-31) — Common Stock: 271331000.00
CIA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 127790000.00
CIA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 2244000.00
CIA cash_flow (annual, 2022-12-31) — Common Stock Payments: -2705000.00
CIA cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1923000.00
CIA cash_flow (annual, 2022-12-31) — Deferred Tax: 1923000.00
CIA cash_flow (annual, 2022-12-31) — Depreciation: 536000.00
CIA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 536000.00
CIA income_statement (annual, 2022-12-31) — Diluted Average Shares: 50867000.00
CIA income_statement (annual, 2022-12-31) — Diluted EPS: 0.51
CIA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 26007000.00
CIA balance_sheet (annual, 2022-12-31) — Dividends Payable: 41663000.00
CIA cash_flow (annual, 2022-12-31) — End Cash Position: 22973000.00
CIA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -499000.00
CIA cash_flow (annual, 2022-12-31) — Free Cash Flow: 56820000.00
CIA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 10291000.00
CIA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -137044000.00
CIA income_statement (annual, 2022-12-31) — General And Administrative Expense: 45177000.00
CIA income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CIA cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 300000.00
CIA balance_sheet (annual, 2022-12-31) — Invested Capital: 127790000.00
CIA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -60742000.00
CIA balance_sheet (annual, 2022-12-31) — Investments And Advances: 1192450000.00
CIA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 2244000.00
CIA income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 128244000.00
CIA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -461000.00
CIA income_statement (annual, 2022-12-31) — Net Income: 26007000.00
CIA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 26007000.00
CIA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 26007000.00
CIA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 26007000.00
CIA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 26007000.00
CIA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 26007000.00
CIA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 26007000.00
CIA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -63274000.00
CIA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -38000.00
CIA balance_sheet (annual, 2022-12-31) — Net PPE: 12926000.00
CIA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -100000.00
CIA income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 128244000.00
CIA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 127790000.00
CIA balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3653000.00
CIA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3653000.00
CIA income_statement (annual, 2022-12-31) — Normalized Income: 26007000.00
CIA cash_flow (annual, 2022-12-31) — Operating Cash Flow: 56920000.00
CIA cash_flow (annual, 2022-12-31) — Operating Gains Losses: 10291000.00
CIA income_statement (annual, 2022-12-31) — Operating Revenue: 232524000.00
CIA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 49822595.00
CIA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -137044000.00
CIA income_statement (annual, 2022-12-31) — Other Gand A: 45177000.00
CIA income_statement (annual, 2022-12-31) — Other Income Expense: 3675000.00
CIA income_statement (annual, 2022-12-31) — Other Operating Expenses: 237000.00
CIA balance_sheet (annual, 2022-12-31) — Other Payable: 1967000.00
CIA balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1180860000.00
CIA balance_sheet (annual, 2022-12-31) — Payables: 11851000.00
CIA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11851000.00
CIA income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 128244000.00
CIA income_statement (annual, 2022-12-31) — Pretax Income: 27377000.00
CIA cash_flow (annual, 2022-12-31) — Purchase Of Investment: -147214000.00
CIA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -100000.00
CIA balance_sheet (annual, 2022-12-31) — Receivables: 16990000.00
CIA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 536000.00
CIA cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -2705000.00
CIA balance_sheet (annual, 2022-12-31) — Retained Earnings: 16309000.00
CIA cash_flow (annual, 2022-12-31) — Sale Of Investment: 83940000.00
CIA cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CIA income_statement (annual, 2022-12-31) — Selling General And Administration: 45177000.00
CIA balance_sheet (annual, 2022-12-31) — Share Issued: 53758176.00
CIA income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CIA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 461000.00
CIA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 127790000.00
CIA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 127790000.00
CIA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (annual, 2022-12-31) — Tax Provision: 1370000.00
CIA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.05
CIA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 601000.00
CIA balance_sheet (annual, 2022-12-31) — Total Assets: 1590703000.00
CIA balance_sheet (annual, 2022-12-31) — Total Capitalization: 127790000.00
CIA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 127790000.00
CIA income_statement (annual, 2022-12-31) — Total Expenses: 205147000.00
CIA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1462913000.00
CIA income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CIA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CIA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 3935581.00
CIA balance_sheet (annual, 2022-12-31) — Treasury Stock: 22806000.00
CIA balance_sheet (annual, 2022-12-31) — Unrealized Gain Loss: -195279000.00
CIA income_statement (annual, 2023-12-31) — +Total Revenue: 240680000.00
CIA balance_sheet (annual, 2023-12-31) — Accounts Payable: 6637000.00
CIA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 15255000.00
CIA cash_flow (annual, 2023-12-31) — Amortization Of Securities: -7297000.00
CIA cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CIA income_statement (annual, 2023-12-31) — Basic Average Shares: 49696000.00
CIA income_statement (annual, 2023-12-31) — Basic EPS: 0.49
CIA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 22973000.00
CIA cash_flow (annual, 2023-12-31) — Capital Expenditure: -442000.00
CIA balance_sheet (annual, 2023-12-31) — Capital Stock: 271859000.00
CIA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 26997000.00
CIA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 26997000.00
CIA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -3536000.00
CIA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -14496000.00
CIA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 22056000.00
CIA cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -922000.00
CIA cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1616000.00
CIA cash_flow (annual, 2023-12-31) — Change In Payable: -1839000.00
CIA cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -1839000.00
CIA cash_flow (annual, 2023-12-31) — Change In Receivables: 1134000.00
CIA cash_flow (annual, 2023-12-31) — Change In Tax Payable: -922000.00
CIA cash_flow (annual, 2023-12-31) — Change In Working Capital: 3713000.00
CIA cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 1134000.00
CIA cash_flow (annual, 2023-12-31) — Changes In Cash: 4024000.00
CIA balance_sheet (annual, 2023-12-31) — Common Stock: 271859000.00
CIA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 65875000.00
CIA cash_flow (annual, 2023-12-31) — Common Stock Payments: -979000.00
CIA cash_flow (annual, 2023-12-31) — Deferred Income Tax: 860000.00
CIA cash_flow (annual, 2023-12-31) — Deferred Tax: 860000.00
CIA cash_flow (annual, 2023-12-31) — Depreciation: 515000.00
CIA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 515000.00
CIA income_statement (annual, 2023-12-31) — Diluted Average Shares: 50681000.00
CIA income_statement (annual, 2023-12-31) — Diluted EPS: 0.48
CIA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 24437000.00
CIA balance_sheet (annual, 2023-12-31) — Dividends Payable: 44960000.00
CIA cash_flow (annual, 2023-12-31) — End Cash Position: 26997000.00
CIA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -3536000.00
CIA cash_flow (annual, 2023-12-31) — Free Cash Flow: 21614000.00
CIA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -760000.00
CIA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -118155000.00
CIA income_statement (annual, 2023-12-31) — General And Administrative Expense: 47131000.00
CIA income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CIA cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1800000.00
CIA balance_sheet (annual, 2023-12-31) — Invested Capital: 172129000.00
CIA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -14496000.00
CIA balance_sheet (annual, 2023-12-31) — Investments And Advances: 82460000.00
CIA balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 82460000.00
CIA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 82460000.00
CIA income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 135433000.00
CIA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -979000.00
CIA income_statement (annual, 2023-12-31) — Net Income: 24437000.00
CIA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 24437000.00
CIA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 24437000.00
CIA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 24437000.00
CIA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 24437000.00
CIA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 24437000.00
CIA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 24437000.00
CIA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -17475000.00
CIA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -2557000.00
CIA balance_sheet (annual, 2023-12-31) — Net PPE: 11809000.00
CIA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -442000.00
CIA income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 135433000.00
CIA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 65875000.00
CIA balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1102000.00
CIA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CIA income_statement (annual, 2023-12-31) — Normalized Income: 24437000.00
CIA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 22056000.00
CIA cash_flow (annual, 2023-12-31) — Operating Gains Losses: -760000.00
CIA income_statement (annual, 2023-12-31) — Operating Revenue: 240680000.00
CIA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49554851.00
CIA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -118155000.00
CIA income_statement (annual, 2023-12-31) — Other Gand A: 47131000.00
CIA income_statement (annual, 2023-12-31) — Other Income Expense: 3627000.00
CIA balance_sheet (annual, 2023-12-31) — Other Payable: 3445000.00
CIA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1238981000.00
CIA balance_sheet (annual, 2023-12-31) — Payables: 10082000.00
CIA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10082000.00
CIA income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 135433000.00
CIA income_statement (annual, 2023-12-31) — Pretax Income: 26174000.00
CIA cash_flow (annual, 2023-12-31) — Purchase Of Investment: -90120000.00
CIA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -442000.00
CIA balance_sheet (annual, 2023-12-31) — Receivables: 16801000.00
CIA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 515000.00
CIA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -979000.00
CIA balance_sheet (annual, 2023-12-31) — Retained Earnings: 42150000.00
CIA cash_flow (annual, 2023-12-31) — Sale Of Investment: 72645000.00
CIA cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CIA income_statement (annual, 2023-12-31) — Selling General And Administration: 47131000.00
CIA balance_sheet (annual, 2023-12-31) — Share Issued: 53882661.00
CIA income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CIA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 588000.00
CIA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 65875000.00
CIA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 65875000.00
CIA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (annual, 2023-12-31) — Tax Provision: 1737000.00
CIA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.07
CIA balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1546000.00
CIA balance_sheet (annual, 2023-12-31) — Total Assets: 1668928000.00
CIA balance_sheet (annual, 2023-12-31) — Total Capitalization: 65875000.00
CIA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 172129000.00
CIA income_statement (annual, 2023-12-31) — Total Expenses: 214506000.00
CIA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1496799000.00
CIA income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CIA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CIA balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 4327810.00
CIA balance_sheet (annual, 2023-12-31) — Treasury Stock: 23725000.00
CIA cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 33000.00
CIA cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 33000.00
CIA cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 33000.00
CIA income_statement (annual, 2024-12-31) — +Total Revenue: 245001000.00
CIA balance_sheet (annual, 2024-12-31) — Accounts Payable: 8822000.00
CIA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 18662000.00
CIA cash_flow (annual, 2024-12-31) — Amortization Of Securities: -18154000.00
CIA income_statement (annual, 2024-12-31) — Basic Average Shares: 49907355.00
CIA income_statement (annual, 2024-12-31) — Basic EPS: 0.30
CIA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 26997000.00
CIA cash_flow (annual, 2024-12-31) — Capital Expenditure: -663000.00
CIA balance_sheet (annual, 2024-12-31) — Capital Stock: 272983000.00
CIA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 27717000.00
CIA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1248678000.00
CIA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -2471000.00
CIA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -27173000.00
CIA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 31918000.00
CIA cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 1398000.00
CIA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1414000.00
CIA cash_flow (annual, 2024-12-31) — Change In Payable: 15152000.00
CIA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 15152000.00
CIA cash_flow (annual, 2024-12-31) — Change In Receivables: -3407000.00
CIA cash_flow (annual, 2024-12-31) — Change In Tax Payable: 1398000.00
CIA cash_flow (annual, 2024-12-31) — Change In Working Capital: 32198000.00
CIA cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -3407000.00
CIA cash_flow (annual, 2024-12-31) — Changes In Cash: 2274000.00
CIA balance_sheet (annual, 2024-12-31) — Common Stock: 272983000.00
CIA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 210355000.00
CIA cash_flow (annual, 2024-12-31) — Common Stock Payments: -393000.00
CIA cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -393000.00
CIA cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1800000.00
CIA cash_flow (annual, 2024-12-31) — Deferred Tax: -1800000.00
CIA cash_flow (annual, 2024-12-31) — Depreciation: 619000.00
CIA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 619000.00
CIA income_statement (annual, 2024-12-31) — Diluted Average Shares: 51420690.00
CIA income_statement (annual, 2024-12-31) — Diluted EPS: 0.29
CIA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 14912000.00
CIA cash_flow (annual, 2024-12-31) — End Cash Position: 29271000.00
CIA cash_flow (annual, 2024-12-31) — Financing Cash Flow: -2471000.00
CIA cash_flow (annual, 2024-12-31) — Free Cash Flow: 31255000.00
CIA cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 2626000.00
CIA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -95965000.00
CIA income_statement (annual, 2024-12-31) — General And Administrative Expense: 52266000.00
CIA cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 500000.00
CIA balance_sheet (annual, 2024-12-31) — Invested Capital: 210355000.00
CIA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -27173000.00
CIA balance_sheet (annual, 2024-12-31) — Investments And Advances: 1319957000.00
CIA balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 93337000.00
CIA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 93337000.00
CIA income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 147149000.00
CIA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -393000.00
CIA cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -393000.00
CIA income_statement (annual, 2024-12-31) — Net Income: 14912000.00
CIA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 14912000.00
CIA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 14912000.00
CIA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 14912000.00
CIA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 14912000.00
CIA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 14912000.00
CIA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 14912000.00
CIA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -30662000.00
CIA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2078000.00
CIA balance_sheet (annual, 2024-12-31) — Net PPE: 10574000.00
CIA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -663000.00
CIA income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 147149000.00
CIA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 210355000.00
CIA balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3442000.00
CIA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 3442000.00
CIA income_statement (annual, 2024-12-31) — Normalized Income: 14912000.00
CIA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 31918000.00
CIA cash_flow (annual, 2024-12-31) — Operating Gains Losses: 2626000.00
CIA income_statement (annual, 2024-12-31) — Operating Revenue: 245001000.00
CIA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 49907355.00
CIA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -95965000.00
CIA income_statement (annual, 2024-12-31) — Other Gand A: 52266000.00
CIA income_statement (annual, 2024-12-31) — Other Income Expense: 4587000.00
CIA balance_sheet (annual, 2024-12-31) — Other Payable: 4546000.00
CIA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1220961000.00
CIA balance_sheet (annual, 2024-12-31) — Payables: 13368000.00
CIA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 13368000.00
CIA income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 147149000.00
CIA income_statement (annual, 2024-12-31) — Pretax Income: 14980000.00
CIA cash_flow (annual, 2024-12-31) — Purchase Of Investment: -100622000.00
CIA cash_flow (annual, 2024-12-31) — Purchase Of PPE: -663000.00
CIA balance_sheet (annual, 2024-12-31) — Receivables: 18810000.00
CIA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 619000.00
CIA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -393000.00
CIA cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -393000.00
CIA balance_sheet (annual, 2024-12-31) — Retained Earnings: 57062000.00
CIA cash_flow (annual, 2024-12-31) — Sale Of Investment: 69960000.00
CIA income_statement (annual, 2024-12-31) — Selling General And Administration: 52266000.00
CIA balance_sheet (annual, 2024-12-31) — Share Issued: 54235165.00
CIA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1517000.00
CIA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 210355000.00
CIA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 210355000.00
CIA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (annual, 2024-12-31) — Tax Provision: 68000.00
CIA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
CIA balance_sheet (annual, 2024-12-31) — Taxes Receivable: 148000.00
CIA balance_sheet (annual, 2024-12-31) — Total Assets: 1685325000.00
CIA balance_sheet (annual, 2024-12-31) — Total Capitalization: 210355000.00
CIA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 210355000.00
CIA income_statement (annual, 2024-12-31) — Total Expenses: 230021000.00
CIA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1474970000.00
CIA balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 4327810.00
CIA balance_sheet (annual, 2024-12-31) — Treasury Stock: 23725000.00
CIA income_statement (quarterly, 2025-03-31) — +Total Revenue: 55652000.00
CIA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 9898000.00
CIA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 17392000.00
CIA cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -2923000.00
CIA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 49908000.00
CIA income_statement (quarterly, 2025-03-31) — Basic EPS: -0.03
CIA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 29271000.00
CIA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -107000.00
CIA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 273499000.00
CIA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18355000.00
CIA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 47900000.00
CIA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -231000.00
CIA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -11433000.00
CIA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 748000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 206000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 131000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Payable: -7649000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -7649000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1270000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 206000.00
CIA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2037000.00
CIA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1270000.00
CIA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -10916000.00
CIA balance_sheet (quarterly, 2025-03-31) — Common Stock: 273499000.00
CIA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 218139000.00
CIA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -370000.00
CIA cash_flow (quarterly, 2025-03-31) — Deferred Tax: -370000.00
CIA cash_flow (quarterly, 2025-03-31) — Depreciation: 161000.00
CIA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 161000.00
CIA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 50912000.00
CIA income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.03
CIA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1623000.00
CIA cash_flow (quarterly, 2025-03-31) — End Cash Position: 18355000.00
CIA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -231000.00
CIA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 641000.00
CIA cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 2894000.00
CIA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -87074000.00
CIA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12693000.00
CIA balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 58000.00
CIA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 218139000.00
CIA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -11433000.00
CIA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1346172000.00
CIA balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 93036000.00
CIA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 93036000.00
CIA income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 36378000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income: -1623000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1623000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1623000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1623000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1623000.00
CIA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1623000.00
CIA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1623000.00
CIA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -11583000.00
CIA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -231000.00
CIA balance_sheet (quarterly, 2025-03-31) — Net PPE: 10164000.00
CIA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -107000.00
CIA income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 36378000.00
CIA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 218139000.00
CIA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4009000.00
CIA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4009000.00
CIA income_statement (quarterly, 2025-03-31) — Normalized Income: -1623000.00
CIA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 748000.00
CIA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2894000.00
CIA income_statement (quarterly, 2025-03-31) — Operating Revenue: 55652000.00
CIA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 49908628.00
CIA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -87074000.00
CIA income_statement (quarterly, 2025-03-31) — Other Gand A: 12693000.00
CIA income_statement (quarterly, 2025-03-31) — Other Income Expense: 1372000.00
CIA balance_sheet (quarterly, 2025-03-31) — Other Payable: 3976000.00
CIA balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 29545000.00
CIA balance_sheet (quarterly, 2025-03-31) — Payables: 13932000.00
CIA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 13932000.00
CIA income_statement (quarterly, 2025-03-31) — Policyholder Benefits Gross: 36378000.00
CIA income_statement (quarterly, 2025-03-31) — Pretax Income: -1787000.00
CIA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -20282000.00
CIA cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -107000.00
CIA balance_sheet (quarterly, 2025-03-31) — Receivables: 17392000.00
CIA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 161000.00
CIA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 55439000.00
CIA cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 8699000.00
CIA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12693000.00
CIA balance_sheet (quarterly, 2025-03-31) — Share Issued: 54236438.00
CIA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 572000.00
CIA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 218139000.00
CIA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 218139000.00
CIA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (quarterly, 2025-03-31) — Tax Provision: -164000.00
CIA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.09
CIA balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 0.00
CIA balance_sheet (quarterly, 2025-03-31) — Total Assets: 1702204000.00
CIA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 218139000.00
CIA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 218139000.00
CIA income_statement (quarterly, 2025-03-31) — Total Expenses: 57439000.00
CIA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1484065000.00
CIA balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 58000.00
CIA balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 4327810.00
CIA balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 23725000.00
CIA income_statement (quarterly, 2025-06-30) — +Total Revenue: 65086000.00
CIA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8411000.00
CIA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 20123000.00
CIA cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -3830000.00
CIA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 50112000.00
CIA income_statement (quarterly, 2025-06-30) — Basic EPS: 0.13
CIA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 18355000.00
CIA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -176000.00
CIA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 274508000.00
CIA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 21117000.00
CIA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 42235000.00
CIA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3952000.00
CIA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 4798000.00
CIA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3470000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -1201000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -732000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Payable: 5237000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 5237000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -2731000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -1201000.00
CIA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1847000.00
CIA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -2731000.00
CIA cash_flow (quarterly, 2025-06-30) — Changes In Cash: 4316000.00
CIA balance_sheet (quarterly, 2025-06-30) — Common Stock: 274508000.00
CIA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 229026000.00
CIA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -5000.00
CIA cash_flow (quarterly, 2025-06-30) — Deferred Tax: -5000.00
CIA cash_flow (quarterly, 2025-06-30) — Depreciation: 182000.00
CIA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 182000.00
CIA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 50985000.00
CIA income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.13
CIA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 6459000.00
CIA cash_flow (quarterly, 2025-06-30) — End Cash Position: 22671000.00
CIA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3952000.00
CIA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 3294000.00
CIA cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2408000.00
CIA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -83655000.00
CIA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 13459000.00
CIA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 229026000.00
CIA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 4798000.00
CIA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1344108000.00
CIA balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 96142000.00
CIA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 96142000.00
CIA income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 37096000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income: 6459000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 6459000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 6459000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 6459000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 6459000.00
CIA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 6459000.00
CIA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 6459000.00
CIA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 3659000.00
CIA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3680000.00
CIA balance_sheet (quarterly, 2025-06-30) — Net PPE: 9845000.00
CIA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -176000.00
CIA income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 37096000.00
CIA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 229026000.00
CIA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4999000.00
CIA balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4999000.00
CIA income_statement (quarterly, 2025-06-30) — Normalized Income: 6459000.00
CIA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3470000.00
CIA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2408000.00
CIA income_statement (quarterly, 2025-06-30) — Operating Revenue: 65086000.00
CIA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 50237716.00
CIA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -83655000.00
CIA income_statement (quarterly, 2025-06-30) — Other Gand A: 13459000.00
CIA income_statement (quarterly, 2025-06-30) — Other Income Expense: 2121000.00
CIA balance_sheet (quarterly, 2025-06-30) — Other Payable: 4010000.00
CIA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 21118000.00
CIA balance_sheet (quarterly, 2025-06-30) — Payables: 12421000.00
CIA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 12421000.00
CIA income_statement (quarterly, 2025-06-30) — Policyholder Benefits Gross: 37096000.00
CIA income_statement (quarterly, 2025-06-30) — Pretax Income: 6914000.00
CIA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -18965000.00
CIA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -176000.00
CIA balance_sheet (quarterly, 2025-06-30) — Receivables: 21266000.00
CIA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 182000.00
CIA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 61898000.00
CIA cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 22624000.00
CIA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 13459000.00
CIA balance_sheet (quarterly, 2025-06-30) — Share Issued: 54565526.00
CIA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1225000.00
CIA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 229026000.00
CIA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 229026000.00
CIA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (quarterly, 2025-06-30) — Tax Provision: 455000.00
CIA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.07
CIA balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1143000.00
CIA balance_sheet (quarterly, 2025-06-30) — Total Assets: 1712500000.00
CIA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 229026000.00
CIA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 229026000.00